Background illustration for clinical trials search

Paid Clinical Trials Indiana

Discover 1,106 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: Worcester MA, New Haven CT, Lebanon NH, New York NY,
Sponsor: Penumbra Inc.

Sex: All

Age: 18+

Code: NCT06747117

Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

for
Huntington Disease
Location: Boston MA, Farmington CT, New York NY, Burlington VT,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 21 - 70

Code: NCT07326709

Phase3, Recruiting
Active & Responsive

Pelvic Health Electrically Evoked Recording (PEER) 2 Study

for
Overactive Bladder, Fecal Incontinence, Urinary Retention
Location: Cleveland OH, Hilliard OH, Indianapolis IN,
Sponsor: MedtronicNeuro

Sex: All

Age: 18+

Code: NCT05200923

Recruiting
Active & Responsive

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

for
Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma,
Location: New York NY, Indianapolis IN, St Louis MO, La Jolla CA
Sponsor: Karie Runcie

Sex: All

Age: 18+

Code: NCT06863311

Phase2, Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Halifax, Boston MA, Quebec, Sherbrooke,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis

for
Neurotrophic Keratitis
Location: Palisades Park NJ, Carmel IN, Town and Country MO,
Sponsor: Krystal Biotech, Inc.

Sex: All

Age: 18+

Code: NCT06999733

Phase1, Phase2, Recruiting
Active & Responsive

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

for
Alpha1-Antitrypsin Deficiency
Location: Halifax, Boston MA, New York NY, Philadelphia PA,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT05677971

Phase3, Recruiting
Active & Responsive

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

for
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Location: Hershey PA, Coral Gables FL, Tampa FL, Ann Arbor MI,
Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois

Sex: All

Age: 0 - 70+

Code: NCT05500807

Phase1, Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: Augusta ME, Boston MA, Providence RI, Concord NH,
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting
Active & Responsive

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

for
Colorectal Cancer
Location: Pennington NJ, Philadelphia PA, Newark DE, Baltimore MD,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06562543

Recruiting
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase2, Recruiting
Active & Responsive

CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting

for
Cardiac Valve Disease
Location: Quebec, Philadelphia PA, Greenville NC, Durham NC,
Sponsor: Corcym S.r.l

Sex: All

Age: 0+

Code: NCT05002543

Recruiting
New

MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients

for
Anxiety Disorders, Stress Disorders, Post-Traumatic,
Location: Indianapolis IN
Sponsor: Indiana University

Sex: Female

Age: 18 - 70+

Code: NCT07540585

Recruiting
New

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

for
Congenital Adrenal Hyperplasia
Location: Hartford CT, Atlanta GA, Ann Arbor MI, Indianapolis IN,
Sponsor: Neurocrine Switzerland GmbH

Sex: All

Age: 0 - 3

Code: NCT07536269

Phase2, Recruiting
New

Assessing Connected-Health, Pressure-Monitoring Technology for Improving Compression Therapy in Venous Leg Ulcer Treatment

for
Venous Leg Ulcers (VLUs)
Location: Fort Wayne IN
Sponsor: Feeltect Limited

Sex: All

Age: 18+

Code: NCT07152717

Recruiting
New

A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)

for
Chronic Pruritus of Unknown Origin
Location: Savannah GA, Boardman OH, Indianapolis IN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07700056

Phase3, Recruiting
New

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Durham NC, Indianapolis IN, North Richland Hills TX
Sponsor: Sanofi

Sex: All

Age: 40+

Code: NCT07612878

Recruiting
New

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

for
Atrial Fibrillation (AF)
Location: Staten Island NY, Ft. Washington MD, Vienna VA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07626411

Phase3, Recruiting
New

A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

for
Cutaneous Lichen Planus
Location: Miami FL, St. Petersburg FL, Fort Gratiot MI, Macon GA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07775924

Phase2, Recruiting
New

A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)

for
Hereditary Hemorrhagic Telangiectasia
Location: Indianapolis IN, Chicago IL, St Louis MO, Rochester MN
Sponsor: Vaderis Therapeutics AG

Sex: All

Age: 18+

Code: NCT07743671

Phase3, Recruiting

Popular cities in Indiana

IndianapolisSouth BendFort WayneEvansville